Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endoxifen in Bipolar I Disorder
NCT04315792Phase 3Completed
- Sponsor
- Jina Pharmaceuticals, Inc.
- Start
- Aug 2020
- Primary completion
- Jan 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of z-endoxifen in bipolar I disorder, sponsored by Jina Pharmaceuticals, Inc.. Started Aug 2020; status: completed.
02
Drugs
z-endoxifen
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT04315792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04315792.